✦ LIBER ✦

Decision analysis model evaluating the cost-effectiveness of risperidone, olanzapine and haloperidol in the treatment of schizophrenia

✍ Scribed by Mark Bounthavong; Mark P. Okamoto

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN3: COST ANALYSIS OF SCHIZOPHRENIA TRE

✍ A Spannheimer; J Clouth; KJ Gregor 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

The cost-analysis of olanzapine compared

✍ S. Almond; O. O'Donnell; J. McKendrick 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 276 KB

Olanzapine, risperidone and haloperidol

✍ D. Gothelf; A. Apter; J. Reidman; A. Brand-Gothelf; Y. Bloch; G. Gal; L. Kikinzo 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 155 KB

A decision model to compare health care

✍ Stephen M. Beard; Fiona Maciver; Johannes Clouth; Eckart Rüther 📂 Article 📅 2006 🏛 Springer 🌐 French ⚖ 874 KB

Benefit-risk evaluation of olanzapine, r

✍ Siegfried Kasper; Anthony Hale; Jean-Michel Azorin; Hans-Jürgen Müller 📂 Article 📅 1999 🏛 Springer-Verlag 🌐 English ⚖ 343 KB

The Impact of Olanzapine, Risperidone, o

✍ P. Joseph Gibson; Robert Damler; E. Anne Jackson; Teresa Wilder; Janet L. Ramse 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB